Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study
Schmieder, G.J., Draelos, Z.D., Pariser, D.M., Banfield, C., Cox, L., Hodge, M., Kieras, E., Parsons‐Rich, D., Menon, S., Salganik, M., Page, K., Peeva, E.
Published in British journal of dermatology (1951) (01.07.2018)
Published in British journal of dermatology (1951) (01.07.2018)
Get full text
Journal Article
Phase 1 dose‐escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXaI16L)
Parsons‐Rich, D., Hua, F., Li, G., Kantaridis, C., Pittman, D. D., Arkin, S.
Published in Journal of thrombosis and haemostasis (01.05.2017)
Published in Journal of thrombosis and haemostasis (01.05.2017)
Get full text
Journal Article